Effects of Various Adjuvants and a Viral Infection on the Antibody Specificity Toward Native or Cryptic Epitopes of a Protein Antigen

An immunization protocol that induces antibodies (Abs) directed to cryptic epitopes of a protein antigen (Ag) reduces the efficacy of vaccines that ideally should induce Abs against native epitopes. We have shown earlier that viral infections concomitant with immunization against a protein tend to shift the Ab specificity toward cryptic epitopes and tend to induce the production of autoantibodies (autoAbs). Here, we show the effects of three adjuvants on the Ab specificity in the absence or presence of a viral infection (lactate dehydrogenase‐elevating virus or LDV), with human growth hormone (hGH) being, as before, the protein Ag.

[1]  R. Rowland,et al.  Lactate dehydrogenase-elevating virus: an ideal persistent virus? , 1995, Springer Seminars in Immunopathology.

[2]  J. Van Snick,et al.  Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms , 2001, International immunology.

[3]  V. Verhasselt,et al.  From autoimmune responses to autoimmune disease: what is needed? , 2001, Journal of autoimmunity.

[4]  F. Destefano,et al.  Epidemiology of autoimmune reactions induced by vaccination. , 2001, Journal of autoimmunity.

[5]  V E Schijns,et al.  Immunological concepts of vaccine adjuvant activity. , 2000, Current opinion in immunology.

[6]  Gómez,et al.  Autoantibodies to Cryptic Epitopes Elicited by Infection with Lactate Dehydrogenase‐Elevating Virus , 2000, Scandinavian journal of immunology.

[7]  Y. Shoenfeld,et al.  Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? , 2000, Journal of autoimmunity.

[8]  N. Dimmock,et al.  Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. , 1999, Vaccine.

[9]  J. Coutelier,et al.  Changes in the Specificity of Antibodies in Mice Infected with Lactate Dehydrogenase‐Elevating Virus , 1997, Scandinavian journal of immunology.

[10]  R. Zinkernagel,et al.  Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. , 1997, Journal of immunology.

[11]  Y. Shoenfeld,et al.  Vaccine-induced autoimmunity. , 1996, Journal of autoimmunity.

[12]  J. Coutelier,et al.  Interleukin-12 gene expression after viral infection in the mouse , 1995, Journal of virology.

[13]  R. Gupta,et al.  Adjuvants for human vaccines--current status, problems and future prospects. , 1995, Vaccine.

[14]  Y. Shoenfeld,et al.  The viral-autoimmunity relationship. , 1995, Viral immunology.

[15]  J. Löwer,et al.  Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. , 1995, Vaccine.

[16]  J. Coutelier,et al.  Inhibition by lactate dehydrogenase-elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. , 1993, Cytokine.

[17]  S. Szu,et al.  Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL. , 1991, Journal of immunology.

[18]  P. Coulie,et al.  In vivo polyclonal B-lymphocyte activation elicited by murine viruses , 1990, Journal of virology.

[19]  J. Snick,et al.  IgG2a restriction of murine antibodies elicited by viral infections , 1987, The Journal of experimental medicine.

[20]  J. Coutelier,et al.  Rheumatoid factor production in 129/Sv mice: involvement of an intestinal infectious agent. , 1986, Journal of immunology.

[21]  B. Mahy,et al.  Lactate dehydrogenase-elevating virus. , 1985, The Journal of general virology.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[23]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.